Annual EBITDA
-$4.79 M
+$3.75 M+43.88%
October 31, 2024
Summary
- As of March 6, 2025, CMND annual EBITDA is -$4.79 million, with the most recent change of +$3.75 million (+43.88%) on October 31, 2024.
- During the last 3 years, CMND annual EBITDA has fallen by -$2.10 million (-77.95%).
- CMND annual EBITDA is now -5886.88% below its all-time high of -$80.00 thousand, reached on October 1, 2019.
Performance
CMND EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$670.30 K
+$785.80 K+53.97%
October 31, 2024
Summary
- As of March 6, 2025, CMND quarterly EBITDA is -$670.30 thousand, with the most recent change of +$785.80 thousand (+53.97%) on October 31, 2024.
- Over the past year, CMND quarterly EBITDA has stayed the same.
- CMND quarterly EBITDA is now -17087.18% below its all-time high of -$3900.00, reached on April 1, 2018.
Performance
CMND Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$4.79 M
+$3.33 M+40.98%
October 31, 2024
Summary
- As of March 6, 2025, CMND TTM EBITDA is -$4.79 million, with the most recent change of +$3.33 million (+40.98%) on October 31, 2024.
- Over the past year, CMND TTM EBITDA has stayed the same.
- CMND TTM EBITDA is now -92007.69% below its all-time high of -$5200.00, reached on October 1, 2017.
Performance
CMND TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CMND EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.9% | 0.0% | 0.0% |
| 3 y3 years | -78.0% | 0.0% | 0.0% |
| 5 y5 years | -5886.9% | -3465.4% | -5791.3% |
CMND EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.0% | +43.9% | at high | +83.2% | -13.0% | +43.9% |
| 5 y | 5-year | -5886.9% | +43.9% | -3465.4% | +83.2% | -5791.3% | +43.9% |
| alltime | all time | -5886.9% | +43.9% | <-9999.0% | +83.2% | <-9999.0% | +43.9% |
Clearmind Medicine EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | -$4.79 M(-43.9%) | -$670.30 K(-54.0%) | -$4.79 M(-41.0%) |
| Jul 2024 | - | -$1.46 M(+13.1%) | -$8.12 M(+4.8%) |
| Apr 2024 | - | -$1.29 M(-6.4%) | -$7.74 M(-4.4%) |
| Jan 2024 | - | -$1.38 M(-65.6%) | -$8.10 M(-5.1%) |
| Oct 2023 | -$8.54 M(+26.1%) | -$4.00 M(+268.4%) | -$8.54 M(+36.3%) |
| Jul 2023 | - | -$1.08 M(-33.9%) | -$6.26 M(-3.4%) |
| Apr 2023 | - | -$1.64 M(-9.3%) | -$6.49 M(-8.1%) |
| Jan 2023 | - | -$1.81 M(+4.9%) | -$7.06 M(+2.7%) |
| Oct 2022 | -$6.77 M(+151.4%) | -$1.73 M(+32.1%) | -$6.87 M(+2.0%) |
| Jul 2022 | - | -$1.31 M(-41.1%) | -$6.74 M(+7.0%) |
| Apr 2022 | - | -$2.22 M(+36.5%) | -$6.30 M(+48.7%) |
| Jan 2022 | - | -$1.62 M(+1.9%) | -$4.24 M(+57.5%) |
| Oct 2021 | -$2.69 M | - | - |
| Oct 2021 | - | -$1.59 M(+83.6%) | -$2.69 M(+108.6%) |
| Jul 2021 | - | -$867.70 K(+464.2%) | -$1.29 M(+171.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2021 | - | -$153.80 K(+99.5%) | -$476.30 K(+29.8%) |
| Jan 2021 | - | -$77.10 K(-59.9%) | -$367.00 K(+18.9%) |
| Oct 2020 | -$309.90 K(+287.4%) | -$192.10 K(+260.4%) | -$308.70 K(+127.8%) |
| Jul 2020 | - | -$53.30 K(+19.8%) | -$135.50 K(+37.3%) |
| Apr 2020 | - | -$44.50 K(+136.7%) | -$98.70 K(+21.4%) |
| Jan 2020 | - | -$18.80 K(-0.5%) | -$81.30 K(+2.4%) |
| Oct 2019 | -$80.00 K(-58.8%) | -$18.90 K(+14.5%) | -$79.40 K(-62.8%) |
| Jul 2019 | - | -$16.50 K(-39.1%) | -$213.30 K(+0.8%) |
| Apr 2019 | - | -$27.10 K(+60.4%) | -$211.60 K(+12.3%) |
| Jan 2019 | - | -$16.90 K(-88.9%) | -$188.40 K(-3.6%) |
| Oct 2018 | -$194.00 K | -$152.80 K(+932.4%) | -$195.40 K(+308.8%) |
| Jul 2018 | - | -$14.80 K(+279.5%) | -$47.80 K(+44.8%) |
| Apr 2018 | - | -$3900.00(-83.7%) | -$33.00 K(+13.4%) |
| Jan 2018 | - | -$23.90 K(+359.6%) | -$29.10 K(+459.6%) |
| Oct 2017 | - | -$5200.00 | -$5200.00 |
FAQ
- What is Clearmind Medicine annual EBITDA?
- What is the all time high annual EBITDA for Clearmind Medicine?
- What is Clearmind Medicine annual EBITDA year-on-year change?
- What is Clearmind Medicine quarterly EBITDA?
- What is the all time high quarterly EBITDA for Clearmind Medicine?
- What is Clearmind Medicine quarterly EBITDA year-on-year change?
- What is Clearmind Medicine TTM EBITDA?
- What is the all time high TTM EBITDA for Clearmind Medicine?
- What is Clearmind Medicine TTM EBITDA year-on-year change?
What is Clearmind Medicine annual EBITDA?
The current annual EBITDA of CMND is -$4.79 M
What is the all time high annual EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high annual EBITDA is -$80.00 K
What is Clearmind Medicine annual EBITDA year-on-year change?
Over the past year, CMND annual EBITDA has changed by +$3.75 M (+43.88%)
What is Clearmind Medicine quarterly EBITDA?
The current quarterly EBITDA of CMND is -$670.30 K
What is the all time high quarterly EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high quarterly EBITDA is -$3900.00
What is Clearmind Medicine quarterly EBITDA year-on-year change?
Over the past year, CMND quarterly EBITDA has changed by $0.00 (0.00%)
What is Clearmind Medicine TTM EBITDA?
The current TTM EBITDA of CMND is -$4.79 M
What is the all time high TTM EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high TTM EBITDA is -$5200.00
What is Clearmind Medicine TTM EBITDA year-on-year change?
Over the past year, CMND TTM EBITDA has changed by $0.00 (0.00%)